Beijing Foyou Pharma Co., Ltd. Class ASSE: 601089

"BEIJING FOYOU PHARMA CO., LTD."Announcement on Obtaining Notice of Approval for Drug Supplementary Application by Subsidiaries

Jul 17, 2026 · Issued by Beijing Foyou Pharma Co., Ltd. Class A via Shanghai Stock Exchange

Announcement on Obtaining Notice of Approval for Drug Supplementary Application by Subsidiaries

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis

Earlier from Beijing Foyou Pharma Co., Ltd. Class A

"BEIJING FOYOU PHARMA CO., LTD."Announcement on the Change of Business License of a Controlled SubsidiaryJul 14
"BEIJING FOYOU PHARMA CO., LTD."Announcement on Inclusion of Products of the Company and Its Subsidiaries in the "National Essential Medicines List (2026 Edition)"Jul 11
"BEIJING FOYOU PHARMA CO.,LTD."Announcement on Obtaining the Drug Supplementary Application Approval Notice for Levothyroxine Sodium TabletsJul 2
Announcement on Approval Notice of the Supplementary Application for Drugs Obtained for Pinaverium Bromide TabletsJun 25

All Beijing Foyou Pharma Co., Ltd. Class A news releases